Stock Events

Stock Events

Sandoz Group 

€71.00
340
+€2.00+2.9% 15:18 Today

Statistics

Day High
71.5
Day Low
67.5
52W High
80.5
52W Low
46.8
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.27%
Dividend
0.9

Upcoming

Dividends

1.27%Dividend Yield
May 26
€0.88
Jun 25
€0.64
Jun 24
€0.46
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
37.43%

Earnings

5AugExpected
Q4 2025
Q2 2026
1.48
1.56
1.64
1.71
Expected EPS
1.50141695
Actual EPS
1.4797827

Financials

8.25%Profit Margin
Profitable
2023
2024
2025
9.43BRevenue
777.52MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow D8Y0.STU. It's not an investment recommendation.
Novartis
132
NOVN.SW
Nestle SA
103
NESN.SW
UBS Group
71
UBSG.SW
Zurich Insurance Group
67
ZURN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap43.22B
Teva Pharmaceutical Industries is a leading global pharmaceutical company that produces generic and specialty medicines, directly competing with Sandoz in the generics market.
Abbvie
ABBV
Mkt Cap454.36B
AbbVie operates in the pharmaceuticals sector focusing on branded drug development, competing with Sandoz's biosimilars and generic pharmaceuticals.
Pfizer
PFE
Mkt Cap157.99B
Pfizer is a research-based biopharmaceutical company that competes with Sandoz in the development and marketing of generic and biosimilar drugs.
Novartis
NVS
Mkt Cap260.7B
Novartis, the parent company of Sandoz, competes in the pharmaceutical industry but is listed separately due to its broader portfolio of patented drugs, which indirectly competes with Sandoz's generics and biosimilars.
Johnson & Johnson
JNJ
Mkt Cap640.02B
Johnson & Johnson is a comprehensive healthcare company that produces a wide range of pharmaceutical products, competing with Sandoz in various therapeutic areas.
Merck
MRK
Mkt Cap355.1B
Merck & Co. is a global healthcare company that produces prescription medicines, vaccines, biologic therapies, and animal health products, competing with Sandoz in the pharmaceutical sector.
GSK
GSK
Mkt Cap96.43B
GlaxoSmithKline is a global healthcare company that researches and develops a wide range of pharmaceutical products, competing with Sandoz in the generics and biosimilars market.
Sanofi
SNY
Mkt Cap102.48B
Sanofi is a global biopharmaceutical company focused on human health, competing with Sandoz in the areas of generic drugs and biosimilars.
Astrazeneca
AZN
Mkt Cap248.41B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Sandoz in developing and marketing biosimilar products and in the generics field.

About

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Show more...
CEO
Richard Saynor
Employees
23000
Country
Switzerland
ISIN
US7999261008
WKN
000A3EVQW

Listings

F
DE
D8Y.F
STU
DE
D8Y0.STU
STU
DE
D8Y.STU
MX
MX
SDZN.MX

0 Comments

Share your thoughts

FAQ

What is Sandoz Group stock price today?▼
The current price of D8Y0.STU is €71.00 EUR — it has increased by +2.9% in the past 24 hours. Watch Sandoz Group stock price performance more closely on the chart.
What is Sandoz Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Sandoz Group stocks are traded under the ticker D8Y0.STU.
Is Sandoz Group stock price growing?▼
D8Y0.STU stock has risen by +2.88% compared to the previous week, the month change is a -9.49% fall, over the last year Sandoz Group has showed a +44.74% increase.
When is the next Sandoz Group earnings date?▼
Sandoz Group is going to release the next earnings report on March 17, 2027.
What were Sandoz Group earnings last quarter?▼
D8Y0.STU earnings for the last quarter are 1.48 EUR per share, whereas the estimation was 1.5 EUR resulting in a -1.44% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Sandoz Group revenue for the last year?▼
Sandoz Group revenue for the last year amounts to 9.43B EUR.
What is Sandoz Group net income for the last year?▼
D8Y0.STU net income for the last year is 777.52M EUR.
Does Sandoz Group pay dividends?▼
Yes, D8Y0.STU dividends are paid annual. The last dividend per share was 0.88 . As of today, Dividend Yield (FWD)% is 1.27%.
How many employees does Sandoz Group have?▼
As of September 17, 2026, the company has 23,000 employees.
In which sector is Sandoz Group located?▼
Sandoz Group operates in the Health & Wellness sector.
When did Sandoz Group complete a stock split?▼
Sandoz Group has not had any recent stock splits.
Where is Sandoz Group headquartered?▼
Sandoz Group is headquartered in Basel, Switzerland.